154 related articles for article (PubMed ID: 27465994)
21. Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.
Gokula V; Terrero D; Joe B
Curr Hypertens Rep; 2022 Dec; 24(12):669-685. PubMed ID: 36301488
[TBL] [Abstract][Full Text] [Related]
22. The SS
Poudel B; Shields CA; Ekperikpe US; Brown AK; Travis OK; Maury JC; Fitzgerald S; Smith SV; Cornelius DC; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2022 Apr; 322(4):R299-R308. PubMed ID: 35107024
[TBL] [Abstract][Full Text] [Related]
23. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure.
Brown AK; Nichols A; Coley CA; Ekperikpe US; McPherson KC; Shields CA; Poudel B; Cornelius DC; Williams JM
Front Physiol; 2021; 12():765305. PubMed ID: 34975523
[TBL] [Abstract][Full Text] [Related]
24. Nephron-deficient HSRA rats exhibit renal injury with age but have limited renal damage from streptozotocin-induced hyperglycemia.
Cobb MB; Wu W; Attipoe EM; Johnson AC; Garrett MR
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1093-F1105. PubMed ID: 33843272
[TBL] [Abstract][Full Text] [Related]
25. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.
Pavlov TS; Palygin O; Isaeva E; Levchenko V; Khedr S; Blass G; Ilatovskaya DV; Cowley AW; Staruschenko A
FASEB J; 2020 Oct; 34(10):13396-13408. PubMed ID: 32799394
[TBL] [Abstract][Full Text] [Related]
26. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.
McPherson KC; Shields CA; Poudel B; Fizer B; Pennington A; Szabo-Johnson A; Thompson WL; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F316-F327. PubMed ID: 30539649
[TBL] [Abstract][Full Text] [Related]
27. The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.
Korczynska J; Czumaj A; Chmielewski M; Swierczynski J; Sledzinski T
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925217
[TBL] [Abstract][Full Text] [Related]
28. Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.
McPherson KC; Taylor L; Johnson AC; Didion SP; Geurts AM; Garrett MR; Williams JM
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F793-F804. PubMed ID: 27465994
[TBL] [Abstract][Full Text] [Related]
29. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
McPherson KC; Shields CA; Poudel B; Johnson AC; Taylor L; Stubbs C; Nichols A; Cornelius DC; Garrett MR; Williams JM
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F911-F921. PubMed ID: 32068459
[TBL] [Abstract][Full Text] [Related]
30. Depletion of macrophages slows the early progression of renal injury in obese Dahl salt-sensitive leptin receptor mutant rats.
Poudel B; Shields CA; Brown AK; Ekperikpe U; Johnson T; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1489-F1499. PubMed ID: 32390513
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing MIP3
Ekperikpe US; Poudel B; Shields CA; Mandal S; Cornelius DC; Williams JM
J Pharmacol Exp Ther; 2023 Mar; 384(3):445-454. PubMed ID: 36507846
[TBL] [Abstract][Full Text] [Related]
32. Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats.
Shields CA; Poudel B; McPherson KC; Brown AK; Ekperikpe US; Browning E; Sutton L; Cornelius DC; Williams JM
Front Physiol; 2020; 11():566403. PubMed ID: 33071820
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]